Berenice Freile
Berenice Freile publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Surgery, on topics such as Gastric Cancer Management and Outcomes, Cancer Immunotherapy and Biomarkers and Esophageal Cancer Research and Treatment.
- World rank
- #5,166,583 of 7,710,434 ranked researchers
- Rank in Argentina
- #16,676 of 38,473
- Works
- 26
- Citations
- 47
- Citations per work
- 1.8
What does Berenice Freile research?
Berenice Freile's work is mostly in Medicine (79%), Biochemistry, Genetics and Molecular Biology (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2078.6%
- Medicine2078.6%
- Everything else417.1%
- Life Sciences14.3%
- 1Oncology29% of their works
- 2Pulmonary and Respiratory Medicine27% of their works
- 3Surgery14% of their works
- 4Pathology and Forensic Medicine6% of their works
- 5Cancer Research4% of their works
- 6Gastroenterology3% of their works
Research topics
- Gastric Cancer Management and Outcomes
- Cancer Immunotherapy and Biomarkers
- Esophageal Cancer Research and Treatment
- Colorectal Cancer Surgical Treatments
- Colorectal Cancer Treatments and Studies
- Cancer Genomics and Diagnostics
- Genetic factors in colorectal cancer
- Gastrointestinal Tumor Research and Treatment
Which keywords describe Berenice Freile's research?
The keywords of their largest research topics: Endoscopic Resection, Chemotherapy, Clinical Practice Guidelines, Molecular Characterization, Gastric Cancer, Lymph Node Dissection, Neoadjuvant Therapy and Preoperative Chemoradiotherapy.
- Imatinib Mesylate
- Microsatellite Instability
- Cancer Genomics
- Laparoscopic Surgery
- Cetuximab
- Barrett's Esophagus
- Immune Checkpoint Blockade
- Preoperative Chemoradiotherapy
- Lymph Node Dissection
- Molecular Characterization
- Chemotherapy
- Endoscopic Resection
- Clinical Practice Guidelines
- Gastric Cancer
- Neoadjuvant Therapy
- Adjuvant Chemotherapy
- PD-1 and PD-L1
- Esophageal Carcinoma
- KRAS Mutations
- Rectal Cancer
- Hereditary Syndromes
- Mutational Signatures
- Sunitinib
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 23 words, with their numbers
- Endoscopic Resection142 topics
- Chemotherapy132 topics
- Clinical Practice Guidelines132 topics
- Molecular Characterization122 topics
- Gastric Cancer91 topic
- Lymph Node Dissection91 topic
- Neoadjuvant Therapy92 topics
- Preoperative Chemoradiotherapy92 topics
- Adjuvant Chemotherapy72 topics
- Immune Checkpoint Blockade61 topic
- PD-1 and PD-L161 topic
- Barrett's Esophagus51 topic
- Esophageal Carcinoma51 topic
- Cetuximab41 topic
- KRAS Mutations41 topic
- Laparoscopic Surgery41 topic
- Rectal Cancer41 topic
- Cancer Genomics31 topic
- Hereditary Syndromes31 topic
- Microsatellite Instability31 topic
- Mutational Signatures31 topic
- Imatinib Mesylate21 topic
- Sunitinib21 topic
Where does Berenice Freile work?
Berenice Freile's main affiliation in the publication record is Instituto Alexander Fleming, Argentina.
How many publications and citations does Berenice Freile have?
OpenAlex counts 26 works and 47 citations for Berenice Freile, an h-index of 4, ranking #5,166,583 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Berenice Freile. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.